First genome-wide association study reveals immune-mediated aetiopathology in idiopathic achalasia.
AuteursGrover S, Gockel I, Latiano A, Mokrowiecka A, Dasmeh P, Wouters MM, Vackova Z, Haas SL, Triantafyllou T, Kreuser N, Trautmann J, Niebisch S, Hess T, Thieme R, Bigge J, Louis H, Quertinmont E, Meirhaeghe A, Muntaner M, Amouyel P, Gourcerol G, Bruley des Varannes S, Mion F, Vieth M, Scarmeas N, Palmieri O, Tavano F, De Giorgio R, Galimberti D, Arighi A, Arosio B, Bruno M, Wasielica-Berger J, Gawron-Kiszka M, Janiak M, Siepsiak M, Adrych K, Marek T, Dabrowski A, Majewski M, Gietka P, Gonciarz M, Pérez de la Serna J, Martínez LZ, Giedraitis V, Kilander L, Fratiglioni L, Real LM, Spicak J, Tack J, Heilmann-Heimbach S, Nöthen M, Ingelsson M, Graff C, Ruiz A, Lambert JC, Ramirez A, Eckardt AJ, Müller M, Knapp M, Wissinowski TT, Keller J, Bruns CJ, Gerges C, Neuhaus H, Rösch T, Siegmund B, Schumacher B, Venerito M, Ruiz de León A, Rosati R, Annese V, Fumagalli U, Laghi L, Urcelay E, Vavasseur F, Roman S, Zhou P, Li Q, Liu Z, Rahden BHAV, Theodorou D, Malecka-Panas E, Maj C, Vigo AG, Martinek J, Boeckxstaens G, Schumacher J
Authors' reply: \"An increase in skin blood flow after red blood cell transfusion is associated with an improvement in organ function in critically ill patients\".
35 years of academic trials focusing on high-dose therapy and autologous stem cell transplantation: the Intergroupe Francophone du Myélome (IFM) experience.
AuteursMoreau P, Hulin C, Talbot A, Demarquette H, Caillot L, Chalopin T, Bobin A, Manier S, Leleu X, Karlin L, Caillot D, Sonntag C, Feugier P, Roussel M, Gounot R, Macro M, Mohty M, Garderet L, Tiab M, Orsini-Piocelle F, Vincent L, Meuleman N, Fontan J, Montes L, Vekemans MC, Escoffre-Barbe M, Eveillard JR, Schiano de Colella JM, Lambert J, Mary JY, Fermand JP, Arnulf B, Corre J, Avet-Loiseau H, Facon T, Harousseau JL, Touzeau C, Perrot A
RSC4All as a machine learning nomogram to predict RSClin™ results in HR+/HER2- node-negative early breast cancer.
AuteursJacobs F, D'Amico S, Ferraro E, Agostinetto E, Tondini C, Gaudio M, Benvenuti C, Gerosa R, Saltalamacchia G, Zazzetti E, Di Rienzo R, Buonaiuto R, Martorana F, Chirco A, De Sanctis R, Della Porta MG, Santoro A, Vigneri P, Arpino MG, Giuliano M, Fornier M, de Azambuja E, Zambelli A
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group.
AuteursBrandão M, Prisciandaro E, Xenophontos E, Mariolo A, Sadeghi AH, Filippi AR, Levy A, Bandura A, Caramella C, Dickhoff C, de Margerie-Mellon C, Faivre-Finn C, Portik D, Sanchez-Lorente D, De Ruysscher D, Smit E, Gobbini E, Fadel E, Ruffini E, Olmetto E, Cortiula F, Bahce I, Houda I, Opitz I, Naidoo J, Edwards J, Remon J, Benitez JC, Trujillo JC, Derks J, Amrane K, Hartemink KJ, Stathopoulos K, Hendriks LEL, Iglesias M, Occhipinti M, Guckenberger M, Giaj Levra N, Girard N, Reguart N, Mercier O, Bironzo P, Hofman P, Petersen RH, De Angelis R, Abgral R, Terrisse S, Popat S, Pierret T, Blum TG, Ricardi U, Dionisi V, Berghmans T, Dingemans AC
Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer.
AuteursLei M, Overman MJ, Yao J, André T, Lonardi S, Lenz HJ, Aglietta M, Gelsomino F, McDermott R, Wong KYM, Morse MA, Van Cutsem E, Hendlisz A, Cardin DB, Neyns B, Hill A, Krishnamurthy A, Chen F, Kochuparambil S, Jenq RR, Abdullaev S, He B, Novosiadly R, Kopetz S
